New shot could help kids and adults fight off infections

NCT ID NCT07346859

Recruiting now Disease control Sponsor: Biopharma Plasma LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new antibody replacement therapy (BP-SCIG 20%) given as a weekly injection under the skin. It aims to see if it is safe and effective at preventing serious infections in people with primary immunodeficiency, a condition where the immune system cannot produce enough antibodies. About 56 children and adults will receive the treatment for a year, and researchers will measure infection rates and antibody levels in the blood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BP-SCIG 20% (human normal immunoglobulin for subcutaneous injection)
What this could lead to: If successful, this could provide a new, well-tolerated option for replacing missing antibodies in people with primary immunodeficiency, helping prevent serious infections.
What could go wrong: This is a relatively small Phase 3 trial (56 participants) and the treatment requires lifelong weekly injections. It may not work for everyone, and side effects like local reactions or allergic responses are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

common variable immunodeficiency inborn error of immunity Primary Immunodeficiency Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY IMMUNODEFICIENCY DISEASES

Contacts and locations

Locations

LLC "Allergy and Cough Clinic"
RECRUITING

Lutsk, 43000, Ukraine
Municipal Enterprise "Volyn Regional Territorial Medical Association for the Protection of Motherhood and Childhood" of the Volyn Regional Council
NOT_YET_RECRUITING

Lutsk, Ukraine
Municipal Non-Profit Enterprise "Central Municipal Hospital" of Rivne City Council
RECRUITING

Rivne, 33017, Ukraine
Municipal Non-Profit Enterprise "Cherkasy Regional Children's Hospital" of the Cherkasy Regional Council
NOT_YET_RECRUITING

Cherkasy, Ukraine
Municipal Non-Profit Enterprise "Ivano-Frankivsk Regional Children's Teaching Hospital" of the Ivano-Frankivsk Regional Council
NOT_YET_RECRUITING

Ivano-Frankivsk, Ukraine
Municipal Non-Profit Enterprise "Ivano-Frankivsk Regional Teaching Hospital" of the Ivano-Frankivsk Regional Council
RECRUITING

Ivano-Frankivsk, 76008, Ukraine
Municipal Non-Profit Enterprise "Kyiv City Children's Teaching Hospital No. 1"
NOT_YET_RECRUITING

Kyiv, 04209, Ukraine
Municipal Non-Profit Enterprise "Vinnytsia Regional Children's Teaching Hospital" of the Vinnytsia Regional Council
NOT_YET_RECRUITING

Vinnytsia, Ukraine
Municipal Non-Profit Enterprise "Vinnytsia Regional Teaching Hospital named after M.I. Pyrohov" of the Vinnytsia Regional Council
NOT_YET_RECRUITING

Vinnytsia, 21018, Ukraine
Municipal Non-Profit Enterprise of the Lviv Regional Council "Clinical Centre of Children's Medicine", structural unit "West Ukrainian Specialised Centre"
NOT_YET_RECRUITING

Lviv, 79035, Ukraine
Municipal Non-Profit Enterprise of the Lviv Regional Council "Lviv Regional Teaching Diagnostic Centre"
RECRUITING

Lviv, 79010, Ukraine
Regional Municipal Non-Profit Enterprise "Chernivtsi Regional Teaching Hospital"
RECRUITING

Chernivtsi, 58001, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.